All In Biotech

Drug Trial Radar · NCT04452344

Opioid Analgesic Reduction Study

Opioid Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain

Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,815 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,815

Actual

Start

Jan 4, 2021

Primary completion

Jul 7, 2023

Study completion Dec 24, 2023

Sponsor

Lead sponsor
Rutgers, The State University of New JerseyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR); University of Rochester; University of Maryland, Baltimore; University of Illinois Chicago; University of Michigan
First posted
Jun 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal is to provide health care professionals, including dentists, with the best possible evidence for clinical decision making when deciding upon analgesics for acute post-surgical pain management, a double-blind, stratified randomized clinical trial will be conducted to test the hypothesis that a combination of over-the-counter non-opioid containing analgesics is at least as, if not more, effective (non-inferior) than the most commonly prescribed opioid analgesic. The impacted 3rd molar extraction model will be used due to the predictable severity of the post-operative pain and generalizability of results. This double-blind, prospective, stratified, randomized pragmatic clinical trial will use the impacted 3rd molar extraction pain model.

Conditions

  • Opioid Use

Interventions

  • opioid-containing analgesicDrug

    hydrocodone/ acetaminophen combination product

  • two over-the-counter analgesicsDrug

    combination of over-the-counter analgesics (ibuprofen/acetaminophen)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Pain 1Time frame: End of day of surgery (day 1) and when waking up the next morning (1 night after surgery)
  2. Composite Pain 2Time frame: End of day of the second day after surgery (day 2) and when waking up the next morning (2nd night after surgery)
  3. Composite Pain 3Time frame: End of day of the third day after surgery (day 3) and when waking up the next morning (3rd night after surgery)
  4. Composite Pain AllTime frame: End of first 7 days after surgery (days 1 thru 7) and when waking up the first 7 mornings (1st thru 7th nights after surgery)
  5. Overall SatisfactionTime frame: At time of post-operative visit (day 9 +/- 5 days)
  6. Pain Worst 1Time frame: End of day of surgery (day 1) and when waking up the next morning (1 night after surgery)
  7. Pain Worst 2Time frame: End of day of after surgery (day 2) and when waking up the next morning (2nd night after surgery
  8. Pain Worst 3Time frame: End of 2nd day of after surgery (day 3) and when waking up the next morning (3rd night after surgery)
  9. Pain Worst AllTime frame: End of first 7 days after surgery (days 1 thru 7) and when waking up the first 7 mornings (1st thru 7th nights after surgery)
  10. Pain Average 1Time frame: End of day of surgery (day 1) and when waking up the next morning (1 night after surgery)
  11. Pain Average 2Time frame: End of day of after surgery (day 2) and when waking up the next morning (2nd night after surgery)
  12. Pain Average AllTime frame: End of first 7 days after surgery (days 1 thru 7) and when waking up the first 7 mornings (1st thru 7th nights after surgery)
  13. Pain Average 3Time frame: End of 2nd day of after surgery (day 3) and when waking up the next morning (3rd night after surgery)

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • University of Illinois at Chicago

    Chicago, Illinois

  • University of Maryland

    Baltimore, Maryland

  • University of Michigan

    Ann Arbor, Michigan

  • Rutgers School of Dental Medicine

    Newark, New Jersey

  • University of Rochester

    Rochester, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.